During the past decade, Hospital Virgen Del Puerto conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Virgen Del Puerto" #1 sponsor was "AstraZeneca" with 3 trials, followed by "PETHEMA Foundation" with 3 trials sponsored, "Pfizer" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Abbott Nutrition" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Virgen Del Puerto" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Adknoma Health Research" with 1 trials as a collaborator, "Dialysis Center SM2. Potenza (Italy)" with 1 trials as a collaborator, "Hospital Arquitecto Marcide. Ferrol. A Coruña. (Spain)" with 1 trials as a collaborator and "Hospital Central de la Defensa Gómez Ulla. Madrid (Spain)" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Virgen Del Puerto" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (3 trials), "Multiple Myeloma" (3 trials), "Alzheimer´s Disease" (1 trials) and "Colorectal Surgery" (1 trials). Many other conditions were trialed in "Hospital Virgen Del Puerto" in a lesser frequency.

Most popular intervention types in "Hospital Virgen Del Puerto" are "Drug" (14 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lanabecestat" (3 trials), "bapineuzumab" (2 trials), "placebo" (2 trials) and "Bapineuzumab 0.5 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Virgen Del Puerto" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Virgen Del Puerto". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hospital Virgen Del Puerto, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Virgen Del Puerto, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital Virgen Del Puerto has several departments that took part in Clinical trials: "Hospital Virgen del Puerto. Servicio de Neurología" - 5 trials